KMT2A and acute myeloid leukemia: Kampen et al., using peptide arrays of normal bone marrow and leukemia cells, demonstrated increased phosphorylation of MAPK pathway proteins in MLL-r AML samples compared to either normal bone marrow or non-MLL-r AML’s (195).